Thursday, September 22, 2016

Lotrel


Lotrel is a brand name of amlodipine/benazepril, approved by the FDA in the following formulation(s):


LOTREL (amlodipine besylate; benazepril hydrochloride - capsule; oral)



  • Manufacturer: NOVARTIS

    Approval date: March 3, 1995

    Strength(s): EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: NOVARTIS

    Approval date: June 20, 2002

    Strength(s): EQ 10MG BASE;20MG [AB]


  • Manufacturer: NOVARTIS

    Approval date: April 11, 2006

    Strength(s): EQ 10MG BASE;40MG [RLD][AB], EQ 5MG BASE;40MG [AB]

Has a generic version of Lotrel been approved?


A generic version of Lotrel has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Lotrel and have been approved by the FDA:


AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (amlodipine besylate; benazepril hydrochloride capsule; oral)



  • Manufacturer: DR REDDYS LABS INC

    Approval date: April 15, 2010

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: DR REDDYS LABS INC

    Approval date: July 5, 2011

    Strength(s): EQ 10MG BASE;40MG [AB], EQ 5MG BASE;40MG [AB]


  • Manufacturer: LUPIN PHARMS

    Approval date: February 5, 2010

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: LUPIN PHARMS

    Approval date: July 5, 2011

    Strength(s): EQ 10MG BASE;40MG [AB], EQ 5MG BASE;40MG [AB]


  • Manufacturer: MYLAN

    Approval date: May 21, 2010

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 5, 2011

    Strength(s): EQ 10MG BASE;40MG [AB], EQ 5MG BASE;40MG [AB]


  • Manufacturer: PAR PHARM

    Approval date: July 29, 2010

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 10MG BASE;40MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB], EQ 5MG BASE;40MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: May 18, 2007

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: July 5, 2011

    Strength(s): EQ 10MG BASE;40MG [AB], EQ 5MG BASE;40MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: October 14, 2010

    Strength(s): EQ 10MG BASE;20MG [AB], EQ 2.5MG BASE;10MG [AB], EQ 5MG BASE;10MG [AB], EQ 5MG BASE;20MG [AB]


  • Manufacturer: WATSON LABS INC

    Approval date: July 5, 2011

    Strength(s): EQ 10MG BASE;40MG [AB], EQ 5MG BASE;40MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lotrel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
    Patent 6,162,802
    Issued: December 19, 2000
    Inventor(s): Papa; Joseph & Henis; Marc M. J.
    A method for the treatment of a variety of cardiovascular disorders and related conditions in a mammal having at least one such disorder or condition is disclosed comprising treating the mammal with cotherapy comprising benazepril and amlodipine or pharmaceutically acceptable salts of either or both. Combination formulations of benazepril and amlodipine for use in the method are also disclosed.
    Patent expiration dates:

    • December 19, 2017
      ✓ 
      Patent use: TREATMENT OF CARDIOVASCULAR DISORDERS


    • December 19, 2017
      ✓ 
      Patent use: METHOD OF TREATING HYPERTENSION
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Lotrel Consumer Information (Drugs.com)
  • Lotrel Consumer Information (Wolters Kluwer)
  • Lotrel Consumer Information (Cerner Multum)
  • Lotrel Advanced Consumer Information (Micromedex)
  • Amlodipine/Benazepril Consumer Information (Wolters Kluwer)
  • Amlodipine and benazepril Consumer Information (Cerner Multum)
  • Amlodipine and benazepril Advanced Consumer Information (Micromedex)
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)